BioPharma Dive report on CEO, employee compensation in biotech and pharma
 Share
The version of the browser you are using is no longer supported. Please upgrade to a supported browser.Dismiss

View only
 
ABCEFGHIJKLMNOPQRSTUVWXYZAAABACADAEAFAG
1
CEO Total compensationEmployee compensationPay ratio% change, 2017 to 2018% stock returnSources
2
CompanyTickerMarket value, as of May 20CEO name
Male/Female
201820172017 CEO (if different)2018201720182017# of employees, as of latest disclosureCEO payEmployee pay20182018 proxy2017 proxy
3
AbbVieABBV$118,000,459,788Rick GonzalezM$21,271,869$22,625,243$148,823$157,347143:1144:130,000-6.0%-5.4%-7.8%https://www.sec.gov/Archives/edgar/data/1551152/000104746919001544/a2238040zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm#dq16701_summary_compensation_table
4
AmgenAMGN$102,707,122,667Robert BradwayM$18,555,266$16,899,789$131,375$132,930141:1127:121,5009.8%-1.2%8.0%https://www.sec.gov/Archives/edgar/data/318154/000119312519100704/d629495ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/318154/000119312518114235/d342855ddef14a.htm
5
GileadGILD$83,744,613,076John MilliganM$25,961,831$15,438,459$163,963$165,007158:194:111,00068.2%-0.6%-16.2%https://www.sec.gov/Archives/edgar/data/882095/000120677419001013/gild3496971-def14a.htmhttps://www.sec.gov/Archives/edgar/data/882095/000120677418000957/gilead3281381-def14a.htm
6
CelgeneCELG$66,879,759,676Bob HuginM$16,223,923$13,115,985$263,237$213,08962:162:18,85223.7%23.5%-41.3%https://www.sec.gov/Archives/edgar/data/816284/000081628419000020/celgenecorp10-ka.htm#sD166CFA4ADA27805EE6FDA62C9E3FEA2https://www.sec.gov/Archives/edgar/data/816284/000114420418023458/tv491624-def14a.htm
7
BiogenBIIB$44,742,839,918Michel VounatsosM$16,168,646$13,664,373$170,521$148,90495:192:17,80018.3%14.5%-11.5%https://www.sec.gov/Archives/edgar/data/875045/000119312519129278/d678705ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/875045/000119312518138852/d519919ddef14a.htm
8
IlluminaILMN$44,186,729,461Francis A. deSouzaM$11,067,566$8,807,716$107,884$102,920103:186:17,30025.7%4.8%30.2%https://www.sec.gov/Archives/edgar/data/1110803/000119312519107277/d639047ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1110803/000119312518109968/d545922ddef14a.htm
9
VertexVRTX$42,446,932,235Jeffrey M. LeidenM$18,799,147$17,227,301$232,178$211,51181:181:12,5009.1%9.8%9.0%https://www.sec.gov/Archives/edgar/data/875320/000130817919000189/lvrt2019_def14a.htmhttps://www.sec.gov/Archives/edgar/data/875320/000130817918000188/lvrt2018_def14a.htm
10
RegeneronREGN$32,595,080,207Leonard S. SchleiferM$26,520,555$26,508,058$134,115$123,418198:1215:17,4000.0%8.7%-5.2%https://www.sec.gov/Archives/edgar/data/872589/000093041319001350/c92333_def14a.htmhttps://www.sec.gov/Archives/edgar/data/872589/000104746918003073/a2234921zdef14a.htm
11
AlexionALXN$28,529,674,262Ludwig HantsonM$16,490,250$15,610,067$223,882$167,28274:193:12,6565.6%33.8%-22.1%https://www.sec.gov/Archives/edgar/data/899866/000089986619000054/a2019proxy.htmhttps://www.sec.gov/Archives/edgar/data/899866/000089986618000069/a2018proxy.htm
12
IncyteINCY$16,475,348,762Hervé HoppenotM$9,314,189$16,087,031$228,006$253,01541:164:11,367-42.1%-9.9%-37.0%https://www.sec.gov/Archives/edgar/data/879169/000119312519082161/d651551ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/879169/000104746918001606/a2234498zdef14a.htm
13
BioMarinBMRN$15,518,293,515Jean-Jacques BienaimeM$15,627,893$15,916,985$160,698$140,14097:1114:12,849-1.8%14.7%-7.5%https://www.sec.gov/Archives/edgar/data/1048477/000120677419001403/bmrn3531801-def14a.htmhttps://www.sec.gov/Archives/edgar/data/1048477/000120677418001344/bmrn3334561-def14a.htm
14
Exact SciencesEXAS$12,402,509,678Kevin T. ConroyM$7,005,506$13,265,089$98,783$98,72471:1135:11,977-47.2%0.1%13.0%https://www.sec.gov/Archives/edgar/data/1124140/000104746919002769/a2238648zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1124140/000104746918003348/a2235369zdef14a.htm
15
Seattle GeneticsSGEN$10,385,433,504Clay SiegallM$18,107,037$8,616,344$198,658$162,44391:153:11,302110.1%22.3%0.1%https://www.sec.gov/Archives/edgar/data/1060736/000106073619000013/proxy2019.htmhttps://www.sec.gov/Archives/edgar/data/1060736/000119312518106501/d536288ddef14a.htm
16
MylanMYL$10,009,782,695Heather BreschF$13,346,299$12,763,539$42,407$40,270315:1317:135,0004.6%5.3%-36.5%https://www.sec.gov/Archives/edgar/data/1623613/000119312519143295/d680644dpre14a.htmhttps://www.sec.gov/Archives/edgar/data/1623613/000119312518178567/d526849ddef14a.htm
17
IonisIONS$9,466,182,705Stanley T. CrookeM$7,625,579$7,314,652$244,261$155,07331:147:17374.3%57.5%8.1%https://www.sec.gov/Archives/edgar/data/874015/000114036119007625/nc10001158x1_def14a.htmhttps://www.sec.gov/Archives/edgar/data/874015/000114036118018201/s002183x1_def14a.htm
18
SareptaSRPT$8,718,285,757Douglas IngramM$1,433,872$57,568,440$329,229$256,1514:1225:1499-97.5%28.5%86.4%https://www.sec.gov/Archives/edgar/data/873303/000156459019013364/srpt-def14a_20190606.htmhttps://www.sec.gov/Archives/edgar/data/873303/000156459018009330/srpt-def14a_20180606.htm
19
SageSAGE$8,358,094,867Jeffrey M. JonasM$9,824,582$5,748,355$589,166$383,68217:115:163770.9%53.6%-43.7%https://www.sec.gov/Archives/edgar/data/1597553/000119312519119608/d679626ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1597553/000119312518139692/d533204ddef14a.htm
20
JazzJAZZ$7,837,873,351Bruce C. CozaddM$11,433,133$10,304,610$216,797$201,09753:151:11,36011.0%7.8%-10.8%https://www.sec.gov/Archives/edgar/data/1232524/000119312519122354/d712716d10ka.htmhttps://www.sec.gov/Archives/edgar/data/1232524/000119312518194458/d565540ddef14a.htm
21
Bio-TechneTECH$7,478,023,734Charles R. KummethM$9,664,874$9,076,890$73,840N/A131:1N/A2,0006.5%N/A7.6%https://www.sec.gov/Archives/edgar/data/842023/000143774918016854/tech20180906_def14a.htmhttps://www.sec.gov/Archives/edgar/data/842023/000143774917015859/tech20170908_def14a.htm
22
BeigeneBGNE$7,467,000,000John V. OylerM$27,895,819$10,291,525$95,217N/A293:1N/A2,200171.1%N/A37.0%https://www.sec.gov/Archives/edgar/data/1651308/000104746919002159/a2238157zpre14a.htmhttps://www.sec.gov/Archives/edgar/data/1651308/000104746918007146/a2236994zdef14a.htm
23
ModernaMRNA$7,435,648,725Stephane BancelM$58,608,484$6,809,189N/AN/AN/AN/A760760.7%N/AN/A
https://www.sec.gov/Archives/edgar/data/1682852/000119312519148153/d689184ddef14a.htm
N/A
24
AlnylamALNY$7,016,526,885John MaraganoreM$5,089,269$1,417,394$243,720$200,64221:17:11,065259.1%21.5%-45.9%https://www.sec.gov/Archives/edgar/data/1178670/000119312519081449/d656786ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1178670/000119312518094195/d519796ddef14a.htm
25
NeurocrineNBIX$6,999,887,187Kevin C. GormanM$8,632,979$7,556,374$259,000$252,00033:130:158514.2%2.8%-13.9%https://www.sec.gov/Archives/edgar/data/914475/000119312519109100/d695930ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/914475/000119312518107644/d474270ddef14a.htm
26
Guardant HealthGH$6,818,334,217Helmy EltoukhyM$818,405$4,136,113N/AN/AN/AN/A454-80.2%N/AN/Ahttps://www.sec.gov/Archives/edgar/data/1576280/000162828019004942/gh-2019xproxy.htmN/A
27
Bluebird bioBLUE$6,696,372,595Nick LeschlyM$23,962,220$8,762,290$239,318$205,167100:142:1764173.5%16.6%-44.8%https://www.sec.gov/Archives/edgar/data/1293971/000156459019012507/blue-def14a_20190606.htmhttps://www.sec.gov/Archives/edgar/data/1293971/000156459018009447/blue-def14a_20180620.htm
28
ExelixisEXEL$5,917,651,054Michael M. MorrisseyM$7,977,535$9,439,583$248,850$275,25432:134:1484-15.5%-9.6%-38.1%https://www.sec.gov/Archives/edgar/data/939767/000119312519103393/d669194ddef14a.htm#toc669194_15https://www.sec.gov/Archives/edgar/data/939767/000119312518114961/d489684ddef14a.htm
29
AscendisASND$5,748,856,489Jan Moller MikkelsenMN/AN/AN/AN/AN/AN/A216N/AN/A57.1%N/AN/A
30
PRA HealthPRAH$5,645,704,960Colin ShannonM$7,870,225$5,951,509$63,345$64,051124:193:116,40032.2%-1.1%1.7%https://www.sec.gov/Archives/edgar/data/1613859/000104746919002379/a2238395zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1613859/000104746918003013/a2235281zdef14a.htm
31
NektarNKTR$5,603,967,100Howard RobinM$13,330,667$18,097,411$162,978$198,86582:191:1618-26.3%-18.0%-43.2%https://www.sec.gov/Archives/edgar/data/906709/000119312519129488/d728572ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/906709/000119312518142660/d543698ddef14a.htm
32
AmarinAMRN$5,565,453,769John TheroM$4,205,779$3,414,788$101,752$135,46141:125:153023.2%-24.9%224.8%https://investor.amarincorp.com/node/16686/htmlhttps://investor.amarincorp.com/node/15276/html
33
GalapagosGLPG$5,535,151,216Onno van de StolpeMN/AN/AN/AN/AN/AN/A725N/AN/A-5.8%N/AN/A
34
GrifolsGRFS$5,000,000,000Victor Grifols Deu, Raimon Grifols RouraMN/AN/AN/AN/AN/AN/A21,230N/AN/A-21.4%N/AN/A
35
GW PharmaGWPH$4,947,000,000Justin GoverM$5,681,411$4,716,296$91,399N/A62:1N/A76920.5%N/A-27.5%https://www.sec.gov/Archives/edgar/data/1351288/000119312519106716/d735842dpre14a.htmN/A
36
HorizonHZNP$4,684,960,588Timothy P. WalbertM$16,796,894$2,342,025$207,196$181,74581:113:11,000617.2%14.0%28.3%https://www.sec.gov/Archives/edgar/data/1492426/000119312519100751/d642487ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1492426/000119312518104871/d527469ddef14a.htm
37
NovocureNVCR$4,680,084,317Asaf DanzigerM$4,570,294$4,311,588$86,053N/A53:1N/A5986.0%N/A59.4%https://www.sec.gov/Archives/edgar/data/1645113/000156459019011243/nvcr-def14a_20190522.htmhttps://www.sec.gov/Archives/edgar/data/1645113/000156459018008602/nvcr-def14a_20180531.htm
38
ArrayARRY$4,647,894,468Ron SquarerM$5,564,866$4,723,485$204,321N/A27:1N/A29817.8%N/A4.9%https://www.sec.gov/Archives/edgar/data/1100412/000104746918006229/a2236632zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1100412/000104746917005811/a2233237zdef14a.htm
39
ArgenxARGX$4,311,508,279Tim Van HauwermeirenMN/AN/AN/AN/AN/AN/A105N/AN/A-79.9%N/AN/A
40
Syneos HealthSYNH$4,306,882,328Alistair MacdonaldM$7,573,682$5,870,074$71,075$70,198107:184:124,00029.0%1.2%-10.2%https://www.sec.gov/Archives/edgar/data/1610950/000161095019000015/syneosproxystatement2019.htmhttps://www.sec.gov/Archives/edgar/data/1610950/000161095018000013/syneosproxystatement2018.htm
41
Spark TherapeuticsONCE$4,135,571,712Jeffrey D. MarrazzoM$3,598,572$4,910,292$182,200$202,88420:124:1368-26.7%-10.2%-29.8%https://www.sec.gov/Archives/edgar/data/1609351/000160935119000045/spark-201810xka.htmhttps://www.sec.gov/Archives/edgar/data/1609351/000160935118000036/a2018proxystatementform.htm
42
United TherapeuticsUTHR$3,850,986,966Martine RothblattF$16,051,966$37,148,572$189,774$182,74785:198:1860-56.8%3.8%-27.4%https://www.sec.gov/Archives/edgar/data/1082554/000104746919002651/a2238579zdef14a.htm#dq18101_pay_ratiohttps://www.sec.gov/Archives/edgar/data/1082554/000104746918003258/a2235419zdef14a.htm#du47601_pay_ratio
43
AlkermesALKS$3,850,436,573Richard F. PopsM$17,078,354$9,403,046$146,775$134,639116:170:12,30081.6%9.0%-47.2%https://www.sec.gov/Archives/edgar/data/1520262/000156459019010920/alks-def14a_20190522.htmhttps://www.sec.gov/Archives/edgar/data/1520262/000155837018002869/def14a.htm
44
Blueprint MedicineBPMC$3,707,041,385Jeffrey AlbersM$9,740,799$4,938,426$398,087$250,03024:120:121797.2%59.2%-35.8%https://www.sec.gov/Archives/edgar/data/1597264/000155837019003477/def14a.htmhttps://www.sec.gov/Archives/edgar/data/1597264/000155837018003430/def14a.htm
45
China BiologicCBPO$3,585,467,149Bing LiMN/AN/AN/AN/AN/AN/A2,187N/AN/A-4.0%N/AN/A
46
AcadiaACAD$3,493,139,691Stephen R. DavisM$6,002,632$15,158,146$207,731$283,05829:154:1430-60.4%-26.6%-45.2%https://www.sec.gov/Archives/edgar/data/1070494/000119312519129723/d664711ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1070494/000119312518143620/d531714ddef14a.htm
47
AllogeneALLO$3,435,907,585David ChangM$12,848,537N/AN/AN/AN/AN/A122N/AN/AN/Ahttps://www.sec.gov/Archives/edgar/data/1737287/000119312519115774/d743180ddef14a.htmN/A
48
UltragenyxRARE$3,364,438,446Emil KakkisM$4,845,627$6,684,899$288,026$297,34817:122:1610-27.5%-3.1%-13.6%https://www.sec.gov/Archives/edgar/data/1515673/000119312519112719/d727791ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1515673/000119312518136529/d556898ddef14a.htm
49
Global BloodGBT$3,201,070,577Ted LoveM$10,260,240$8,018,998$297,580N/A34:1N/A17127.9%N/A-3.1%https://www.sec.gov/Archives/edgar/data/1629137/000119312519125149/d644795ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1629137/000119312518134761/d572060ddef14a.htm
50
RepligenRGEN$3,176,353,600Tony J. HuntM$13,893,326$3,044,785$96,477$64,014144:148:1540356.3%50.7%42.5%https://www.sec.gov/Archives/edgar/data/730272/000119312519111021/d686074ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/730272/000119312518123735/d529721ddef14a.htm
51
FibrogenFGEN$3,086,897,977Thomas NeffM$9,224,044$7,088,691$212,858$160,92543:144:146130.1%32.3%-8.0%https://www.sec.gov/Archives/edgar/data/921299/000156459019012506/0001564590-19-012506-index.htmhttps://www.sec.gov/Archives/edgar/data/921299/000156459018008877/fgen-def14a_20180605.htm
52
ImmunoMedicsIMMU$2,957,331,199Michael PehlM$1,371,964$1,389,498Cynthia Sullivan $43,427N/A32:1N/A346-1.3%N/A-11.0%https://www.sec.gov/Archives/edgar/data/722830/000072283019000008/a2019proxy.htmhttps://www.sec.gov/Archives/edgar/data/722830/000155837018001461/def14a.htm#SummaryCompensationTable_334287
53
MorphosysMOR$2,917,849,617Simon MoroneyM$1,936,669$1,547,606N/AN/AN/AN/A32925.1%N/AN/AN/AN/A
54
AgiosAGIO$2,853,957,787David P. SchenkeinM$8,199,324$5,972,364$345,181$253,11524:124:148237.3%36.4%-26.0%https://www.sec.gov/Archives/edgar/data/1439222/000119312519110870/d685927ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1439222/000119312518121025/d513033ddef14a.htm
55
Chi-MedHCM$2,812,956,839Christian HoggMN/AN/AN/AN/AN/AN/A714N/AN/A-42.5%N/AN/A
56
InterceptICPT$2,743,293,668Mark PruzanskiM$4,525,960$6,154,687$244,883$218,93818:128:1483-26.5%11.9%78.3%https://www.sec.gov/Archives/edgar/data/1270073/000114420419022368/tv519111-def14a.htmhttps://www.sec.gov/Archives/edgar/data/1270073/000114420418023198/tv491398-def14a.htm
57
BioHavenBHVN$2,739,171,533Vlad CoricM$7,854,000$3,855,665N/AN/AN/AN/A63103.7%N/A30.1%https://www.sec.gov/Archives/edgar/data/1689813/000168981319000020/a2019bhvndef14aproxystatem.htmhttps://www.sec.gov/Archives/edgar/data/1689813/000104746918002346/a2235115zdef14a.htm
58
AmicusFOLD$2,728,530,403John F. CrowleyM$7,419,963$5,613,080$152,717$184,51449:130:150832.2%-17.2%-38.9%https://www.sec.gov/Archives/edgar/data/1178879/000104746919002700/a2238631zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1178879/000104746918003259/a2235408zdef14a.htm
59
ReataRETA$2,689,709,585J. Warren HuffM$934,500$5,114,978N/AN/AN/AN/A123-81.7%N/A101.9%https://www.sec.gov/Archives/edgar/data/1358762/000156459019013939/reta-def14a_20190612.htmhttps://www.sec.gov/Archives/edgar/data/1358762/000156459018009659/reta-def14a_20180613.htm
60
ArenaARNA$2,651,998,210Amit D. MunshiM$6,863,445$2,915,945$261,005$182,39726:116:1194135.4%43.1%-3.0%https://www.sec.gov/Archives/edgar/data/1080709/000156459019013997/arna-def14a_20190613.htmhttps://www.sec.gov/Archives/edgar/data/1080709/000119312518143053/d575771ddef14a.htm
61
MiratiMRTX$2,549,964,702Charles M. BaumM$4,868,079$1,622,101N/AN/AN/AN/A63200.1%N/A123.3%https://www.sec.gov/Archives/edgar/data/1576263/000162828019004534/mirati2019proxy.htmhttps://www.sec.gov/Archives/edgar/data/1576263/000162828018004805/mirati2018proxy.htm
62
Medicines CompanyMDCO$2,529,588,408Mark TimneyM$9,677,655$7,607,885Clive A. Meanwell$659,048$230,46115:133:16227.2%186.0%-31.0%https://www.sec.gov/Archives/edgar/data/1113481/000111348119000017/mdco-2019xdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1113481/000111348118000029/mdco-2018xdef14a.htm
63
UniQureQURE$2,308,762,989Matthew KapustaM$4,095,328$3,929,535$111,598N/A37:1N/A2124.2%N/A45.4%https://www.sec.gov/Archives/edgar/data/1590560/000110465919024566/a19-2719_1pre14a.htmhttps://www.sec.gov/Archives/edgar/data/1590560/000110465918058729/a18-35054_1def14a.htm
64
MyokardiaMYOK$2,275,446,661Tassos GianakakosM$8,974,780$3,210,258N/AN/AN/AN/A165179.6%N/A16.2%https://www.sec.gov/Archives/edgar/data/1552451/000156459019012704/myok-def14a_20190613.htmhttps://www.sec.gov/Archives/edgar/data/1552451/000156459018008282/myok-def14a_20180612.htm
65
Emergent BioSolutionsEBS$2,225,619,960Daniel J. Abdun-NabiM$4,473,508$3,681,284$96,445$90,36146:141:11,70521.5%6.7%24.0%https://www.sec.gov/Archives/edgar/data/1367644/000104746919002216/a2238412zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1367644/000114036118018425/bp06078x2_def14a.htm
66
HalozymeHALO$2,216,102,003Helen I. TorleyF$5,799,669$5,180,551$199,899$206,37429:125:128112.0%-3.1%-28.7%https://www.sec.gov/Archives/edgar/data/1159036/000115903619000013/halodefproxy2019.htmhttps://www.sec.gov/Archives/edgar/data/1159036/000115903618000017/haloproxy2018.htm
67
LigandLGND$2,206,342,875John L. HigginsM$6,306,833$5,513,207$262,940$244,29724:123:111614.4%7.6%-4.1%https://www.sec.gov/Archives/edgar/data/886163/000088616319000063/lgnd-2019annualmeetingproxy.htmhttps://www.sec.gov/Archives/edgar/data/886163/000088616318000056/lgnd-2018annualmeetingproxy.htm
68
PTC TherapeuticsPTCT$2,184,735,054Stuart W. PeltzM$4,016,735$2,172,683$218,196$163,26518:113:151784.9%33.6%90.6%https://www.sec.gov/Archives/edgar/data/1070081/000107008119000023/ptct2019proxy.htmhttps://www.sec.gov/Archives/edgar/data/1070081/000107008118000046/ptct2018proxy.htm
69
InsmedINSM$2,180,093,017William H. LewisM$5,943,159$4,352,433$220,257$235,73327:118:137336.5%-6.6%-60.2%https://www.sec.gov/Archives/edgar/data/1104506/000104746919001953/a2238363zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1104506/000104746918002564/a2235219zdef14a.htm
70
AcceleronXLRN$2,160,641,288Habib J. DableM$4,333,647$1,322,314$211,324$158,21021:18:1173227.7%33.6%-1.9%https://www.sec.gov/Archives/edgar/data/1280600/000128060019000022/xlrn-2019proxystatement.htmhttps://www.sec.gov/Archives/edgar/data/1280600/000128060018000021/xlrn-2018proxystatement.htm
71
Genomic HealthGHDX$2,024,894,448Kimberly J. PopovitsF$4,712,889$4,123,305$177,966$166,10626:125:182914.3%7.1%89.2%https://www.sec.gov/Archives/edgar/data/1131324/000155837019003311/def14a.htmhttps://www.sec.gov/Archives/edgar/data/1131324/000155837018003417/def14a.htm
72
MedpaceMEDP$1,996,551,120August J. TroendleM$528,290$598,083N/AN/AN/AN/A2,900-11.7%N/A42.0%https://www.sec.gov/Archives/edgar/data/1668397/000156459019010712/medp-def14a_20190517.htmhttps://www.sec.gov/Archives/edgar/data/1668397/000156459018007678/medp-def14a_20180518.htm
73
CRISPRCRSP$1,992,971,747Samarth KulkarniM$9,727,532$6,934,265N/AN/AN/AN/A18840.3%N/A21.5%https://www.sec.gov/Archives/edgar/data/1674416/000119312519129267/d660374ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1674416/000119312518121109/d556965ddef14a.htm
74
DenaliDNLI$1,966,846,836Ryan J. WattsM$5,986,614$1,366,863N/AN/AN/AN/A179 338.0%N/A24.1%https://www.sec.gov/Archives/edgar/data/1714899/000171489919000022/fy18def14aproxy.htmhttps://www.sec.gov/Archives/edgar/data/1714899/000119312518134885/d463334ddef14a.htm
75
PortolaPTLA$1,946,583,794Scott GarlandM$6,285,250$4,885,803William Lis$293,059$389,90721:113:132428.6%-24.8%-60.5%https://www.sec.gov/Archives/edgar/data/1269021/000156459019012150/ptla-def14a_20190613.htmhttps://www.sec.gov/Archives/edgar/data/1269021/000156459018008886/ptla-def14a_20180608.htm
76
IovanceIOVA$1,928,056,619Maria FardisF$9,394,600$850,000$312,125$284,35430:13:1881005.2%9.8%7.9%https://www.sec.gov/Archives/edgar/data/1425205/000114420419021965/tv519967_def14a.htmhttps://www.sec.gov/Archives/edgar/data/1425205/000114420418022424/tv491717_def14a.htm
77
AllakosALLK$1,862,525,500Robert AlexanderM$8,072,610$1,096,557N/AN/AN/AN/A62636.2%N/AN/Ahttps://www.sec.gov/Archives/edgar/data/1564824/000156459019014336/allk-def14a_20190606.htmN/A
78
AnaptysBioANAB$1,852,495,282Hamza SuriaM$5,122,232$4,016,438N/AN/AN/AN/A7827.5%N/A-36.8%https://www.sec.gov/Archives/edgar/data/1370053/000137005319000013/proxystatementfy2018.htmhttps://www.sec.gov/Archives/edgar/data/1370053/000137005318000020/proxystatementfy2017.htm
79
Myriad GeneticsMYGN$1,848,999,655Mark C. CaponeM$7,054,950$5,217,895$77,814N/A91:1N/A2,40035.2%N/A-17.2%https://www.sec.gov/Archives/edgar/data/899923/000119312518296456/d616630ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/899923/000119312517308380/d462900ddef14a.htm
80
XencorXNCR$1,848,951,194Bassil I. DahiyatM$4,372,828$4,999,797$179,109$178,24924:128:1156-12.5%0.5%57.8%https://www.sec.gov/Archives/edgar/data/1326732/000155837019003579/def14a.htmhttps://www.sec.gov/Archives/edgar/data/1326732/000155837018003416/def14a.htm
81
AkceaAKCA$1,847,978,407Paula SoteropoulosF$5,209,531$3,412,710N/AN/AN/AN/A24852.7%N/A77.4%https://www.sec.gov/Archives/edgar/data/1662524/000119312519123848/d610718ddef14c.htmhttps://www.sec.gov/Archives/edgar/data/1662524/000114036118014875/s002111x5_def14a.htm
82
AerieAERI$1,797,689,770Vicente AnidoM$6,774,726$10,057,110$171,192N/A40:1N/A353-32.6%N/A-40.4%https://www.sec.gov/Archives/edgar/data/1337553/000162828019004113/aerieproxy2019.htmhttps://www.sec.gov/Archives/edgar/data/1337553/000162828018005256/aerieproxy2018.htm
83
ArrowheadARWR$1,795,778,725Christopher AnzaloneM$1,619,9011,871,214$134,747N/A12:1N/A116-13.4%N/A167.7%https://www.sec.gov/Archives/edgar/data/879407/000119312519017078/d687022ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/879407/000119312518019852/d502300ddef14a.htm
84
Pacira BioSciencesPCRX$1,788,986,027David StackM$5,835,918$4,718,917$177,153$166,42733:128:151823.7%6.4%-7.2%https://www.sec.gov/Archives/edgar/data/1396814/000104746919002459/a2238549zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1396814/000104746918003298/a2235506zdef14a.htm
85
Zai LabZLAB$1,780,754,150Samantha DuFN/AN/AN/AN/AN/AN/A309N/AN/A3.9%N/AN/A
86
TricidaTCDA$1,778,868,037Gerrit KlaernerM$1,497,065$821,005N/AN/AN/AN/A7682.3%N/AN/Ahttps://www.sec.gov/Archives/edgar/data/1595585/000114420419020252/tv518825-def14a.htm#tEC-SCTN/A
87
Enanta ENTA$1,775,807,575Jay LulyM$4,508,737$4,281,102N/AN/AN/AN/A1135.3%N/A20.7%https://www.sec.gov/Archives/edgar/data/1177648/000119312519012894/d659936ddef14a.htm#toc659936_11https://www.sec.gov/Archives/edgar/data/1177648/000156459018000659/enta-def14a_20180228.htm
88
IronwoodIRWD$1,735,177,435Peter M. HechtM$5,160,116$5,995,456$194,750$162,17726:137:1515-13.9%20.1%-33.4%https://www.sec.gov/Archives/edgar/data/1446847/000104746919002641/a2238587zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1446847/000104746918003404/a2235543zdefc14a.htm
89
SupernusSUPN$1,733,910,320Jack KhattarM$7,215,836$5,570,924$131,026$130,20055:143:144829.5%0.6%-20.3%https://www.sec.gov/Archives/edgar/data/1356576/000104746919002684/a2238573zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1356576/000104746918003310/a2235487zdef14a.htm
90
AudentesBOLD$1,718,469,038Matthew PattersonM$780,480$6,927,180N/AN/AN/AN/A207-88.7%N/A-40.0%https://www.sec.gov/Archives/edgar/data/1628738/000156459019013369/bold-def14a_20190607.htmhttps://www.sec.gov/Archives/edgar/data/1628738/000156459018009595/bold-def14a_20180608.htm
91
Invitae NVTA$1,596,474,611Sean E. GeorgeM$2,233,360$3,563,844N/AN/AN/AN/A788-37.3%N/A16.1%https://www.sec.gov/Archives/edgar/data/1501134/000119312519129233/d699638ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1501134/000119312518108706/d439012ddef14a.htm
92
OrchardORTX$1,593,664,747Mark RotheraMN/AN/AN/AN/AN/AN/A180N/AN/AN/AN/AN/A
93
ZogenixZGNX$1,579,840,171Stephen J. FarrM$6,650,252$1,980,634$312,870$239,66521:18:190235.8%30.5%-2.8%https://www.sec.gov/Archives/edgar/data/1375151/000119312519101767/d713449ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1375151/000137515118000021/a2018proxy.htm
94
NateraNTRA$1,568,806,603Matthew RabinowitzM$5,367,507$3,004,932N/AN/AN/AN/A97578.6%N/A46.8%https://www.sec.gov/Archives/edgar/data/1604821/000104746919001966/a2238339zdef14a.htm#cg40001_summary_compensation_tablehttps://www.sec.gov/Archives/edgar/data/1604821/000104746918002528/a2235171zdef14a.htm#cg70001_summary_compensation_table
95
RegenxbioRGNX$1,538,754,000Kenneth T. MillsM$4,938,199$2,558,661N/AN/AN/AN/A19293.0%N/A17.2%https://www.sec.gov/Archives/edgar/data/1590877/000119312519103878/d713258ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1590877/000119312518115568/d512518ddef14a.htm
96
MadrigalMDGL$1,538,408,021Paul A. FriedmanM$5,628,666$1,364,982$804,000N/A7:1N/A17312.4%N/A14.0%https://www.sec.gov/Archives/edgar/data/1157601/000119312519129437/d729391d10ka.htmhttps://www.sec.gov/Archives/edgar/data/1157601/000114036118020146/bp09373x1_def14a.htm
97
ArvinasARVN$1,440,457,521John HoustonM$6,279,556$954,429N/AN/AN/AN/A83557.9%N/AN/Ahttps://www.sec.gov/Archives/edgar/data/1655759/000119312519105281/d724614ddef14a.htmN/A
98
InnovivaINVA$1,438,937,286Geoffrey L. HulmeM$500,333$4,176,840Michael W. Aguiar$230,635$382,4602:111:16-88.0%-39.7%23.4%https://www.sec.gov/Archives/edgar/data/1080014/000104746919001164/a2238030zdef14a.htmhttps://www.sec.gov/Archives/edgar/data/1080014/000104746918002075/a2234992zdef14a.htm
99
EndoENDP$1,411,375,628Paul V. CampanelliM$19,970,703$13,602,395$82,233$79,553243:1171:12,91046.8%3.4%-17.6%https://www.sec.gov/Archives/edgar/data/1593034/000119312519125159/d675822ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/1593034/000119312518138794/d467506ddef14a.htm
100
HeronHRTX$1,410,449,372Barry QuartM$5,991,297$4,243,100$418,130$339,58914:113:16841.2%23.1%37.3%https://www.sec.gov/Archives/edgar/data/818033/000119312519122529/d655532ddef14a.htmhttps://www.sec.gov/Archives/edgar/data/818033/000119312518140977/d546548ddef14a.htm
Loading...